Janine Reichenbach

Prof. Dr. med. Janine Reichenbach is a full professor and head of the Somatic Gene Therapy department at the University of Zurich, affiliated with the University Children's Hospital Zurich. She holds dual board certifications in Pediatrics and Adolescent Medicine (Germany/Switzerland) and Allergology & Clinical Immunology (Switzerland). Her career spans over two decades of translational research bridging basic science and clinical implementation of gene therapies.

• Education: MD from Goethe University Frankfurt (1995-1997), medical training in Germany (1997-2000), and specialist certifications in Switzerland (2005-2009).
• Research Focus: Translational development of hematopoietic stem cell-based gene therapies for primary immunodeficiencies, particularly chronic granulomatous disease (CGD) and ataxia telangiectasia (A-T). Key projects include lentiviral vector design, genome editing at ATM locus, and myeloid-targeted therapies with brain-crossing potential.
• Awards: Recipient of the 2010 Walther und Gertrud Siegenthaler Stiftung prize.
• Grants: Leads Swiss National Science Foundation projects, University Research Priority Programs (URPP Itinerare), Clinical Research Priority Programs (CRPP ImmuGene), and Wyss Centre collaborations.
• Leadership: Principal investigator in EU-FP7 projects CELL-PID and NET4CGD, steering committee member for SCID newborn screening, and co-founder of international research networks.